協和キリン

4151JPPrimePharmaceuticals & Healthcare

協和キリン

Revenue

¥442bn

FY2023

Operating income

¥53bn

FY2023

Employees

—

Founded

—

Source: EDINET website (https://disclosure.edinet-fsa.go.jp/) — edited by PollNow